Search

Displaying results 2391 - 2400 of 10000 in total
  1. Drug

    Phenoxyethanol

    go.drugbank.com/drugs/DB11304
    ApprovedInvestigational

    According to the European Union Cosmetics Regulation (EC) n.1223/2009, phenoxyethanol is authorized as a preservative in cosmetic formulations at a maximum concentration of 1.0% [L2625]. … It is very easy to use in various types of formulations and is chemically stable.

    Mixtures: Linola sept 1 mg/g + 10 mg/g Wund-Gel, FITO INTERTULLE, 10 ADET
  2. Drug

    Tiopronin

    go.drugbank.com/drugs/DB06823
    Approved

    It is similar to d-penicillamine in use and efficacy, but offers the advantage of far less adverse effects. … Tiopronin may also be used to bind metal nanoparticles in Wilson's disease, which is an overload of copper in the body.

  3. Drug

    Simoctocog alfa

    go.drugbank.com/drugs/DB09108
    Approved

    plasma-derived FVIII, has been deleted and replaced by a 16 amino acid linker. … Simoctocog alfa is a glycoprotein consisting of 1440 amino acids with an approximate molecular mass of 170 kDa, comprising the FVIII domains A1-A2 + A3-C1-C2 whereas the B-domain, present in the full-length

    Products: NUWIQ 500 UI
  4. Drug

    Cupric oxide

    go.drugbank.com/drugs/DB11134
    Approved

    The mean daily dietary intake of copper in adults ranges between 0.9 and 2.2 mg [L2422]. Common routes of cupric oxide exposure include ingestion, dermal exposure and inhalation. … Cupric oxide poses potential health and environmental concern due to toxic and mutagenic particles generating reactive oxygen species [A32656].

    Mixtures: PreQue 10, PreQue 10
  5. Indication

    Radiation sickness

    go.drugbank.com/conditions/DBCOND0022553
    Drugs: Potassium Iodide
    Synonyms: Disorder due to exposure to radiation, Disorder due to exposure to ionising radiation
  6. Drug

    Fenobam

    go.drugbank.com/drugs/DB12931
    Investigational

    Fenobam is under investigation in clinical trial NCT00637221 (Open Label Study Investigating Safety and Efficacy of Fenobam anhydrous 50 mg - 150 mg on Prepulse Inhibition Tests and Continuous Performance

  7. Drug

    Reloxaliase

    go.drugbank.com/drugs/DB15560
    Investigational

    Reloxaliase is a crystalline formulation of oxalate decarboxylase derived from Bacillus Subtilis. Reloxaliase is under investigation in clinical trial NCT03456830 (Evaluate ALLN-177 in Patients With Enteric Hyperoxaluria).

    Synonyms: Oxalate decarboxylase (bacillus subtilis (strain 168))
  8. Drug

    Artemisia vulgaris root

    go.drugbank.com/drugs/DB14170
    Approved

    Artemisia vulgaris root allergenic extract is used in allergenic testing.

    Mixtures: Toe Corrector CompositeProducts: LAIS Beifuß 1000 UA Sublingualtabletten
  9. Drug

    Influenza A virus A/Singapore/INFIMH-16-0019/2016 IVR-186 (H3N2) antigen (UV, formaldehyde inactivated)

    go.drugbank.com/drugs/DB14560
    ApprovedWithdrawn

    Vaccines provide protection from influenza by exposing the immune system to the virus (or parts of the virus) which stimulates an immunological defence against future exposure to the virus, or "antigen … that it was previously exposed to.

    Mixtures: VAXİGRİP 0,5 ML IM/SC ENJEKSİYON İÇİN SÜSPANSİYON İÇEREN KULLANIMA HAZIR ENJEKTÖR , 10 ADET, VAXİGRİP TETRA 0,5 ML IM/SC ENJEKSİYON İÇİN SÜSPANSİYON İÇEREN KULLANIMA HAZIR ENJEKTÖR , 1 ADETSynonyms: Influenza A virus A/Singapore/INFIMH-16-0019/2016 IVR-186 (H3N2) antigen (UV, formaldehyde inactivated)
  10. Drug

    Articaine

    go.drugbank.com/drugs/DB09009
    ApprovedInvestigational

    Articaine is a dental local anesthetic. Articaine is widely used around the world and is the most popular local anesthetic in many European countries.

    Mixtures: Orabloc 40 mg/ml + 10 Mikrogramm/ml Injektionslösung, Sopira Citocartin 40 mg/ml + 10 Mikrogramm/ml Injektionslösung